The Economics of the Hematopoietic Growth Factors

摘要: The last two decades have seen a dramatic increase in overall healthcare costs. Cancer treatment cost the United States has increased by about 75% between 1995 and 2008, accounting for $93.2 billion direct medical costs [1, 2]. Spending on cancer drugs faster than spending other areas of (such as hospitalization), due to both increases prices rates use. Of particular concern is that magnitude exceeds their improvement efficacy [3].